About this episode

This episode discusses the efficacy of Guselkumab across the PsA disease spectrum and reviews various trials related to inflammatory arthritis treatments.

Guselkumab Delivers Across the PsA Disease Spectrum: APEX TrialRA BRIDGE and RA BRANCH trials: Baricitinib and VTE RiskImproving Referrals for Inflammatory Arthritis"Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease

People in this episode

Host: Dr. Cush

Topics covered

• PsA Disease Spectrum
• Inflammatory Arthritis
• Combination Therapy
• Rheumatic Disease
• VTE Risk

Keywords

• Guselkumab
• PsA
• Baricitinib
• RA BRIDGE
• RA BRANCH
• Rituximab
• VTE Risk
• Combination Therapy
• Inflammatory Arthritis

Mentioned in this episode

Organizations: EULAR

Products: Guselkumab, Baricitinib, Rituximab

More episodes of Rheumnow Podcast

• RheumNow EULAR 2026 Rheumatology Round Up · June 12, 2026 · 56 min
• EULAR 2026 RA Topic Panel · June 11, 2026 · 54 min
• CAR-T Topic Panel EULAR 2026 · June 10, 2026 · 38 min
• EULAR 2026 PsA Update What's Changing in Psoriatic Arthritis Care? · June 9, 2026 · 49 min
• RA Topic Podcast compilation · June 8, 2026 · 1h 35m
• PsA Topic Podcast compilation · June 8, 2026 · 1h 37m

Explore listener stats, chart rankings, contacts and more on the Rheumnow Podcast podcast page.